Fidelity Investments’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Buy |
81,639
+500
| +0.6% | +$14.7K | ﹤0.01% | 2430 |
|
|
2025
Q1 | $2.09M | Buy |
81,139
+80,927
| +38,173% | +$2.08M | ﹤0.01% | 2431 |
|
|
2024
Q4 | $6.12K | Buy |
212
+78
| +58% | +$2.25K | ﹤0.01% | 4616 |
|
|
2024
Q3 | $3.18K | Buy |
134
+37
| +38% | +$878 | ﹤0.01% | 4709 |
|
|
2024
Q2 | $1.68K | Sell |
97
-1,276
| -93% | -$22.1K | ﹤0.01% | 4745 |
|
|
2024
Q1 | $30.7K | Buy |
1,373
+1,223
| +815% | +$27.3K | ﹤0.01% | 3814 |
|
|
2023
Q4 | $2.75K | Buy |
150
+36
| +32% | +$660 | ﹤0.01% | 4586 |
|
|
2023
Q3 | $1.99K | Sell |
114
-71
| -38% | -$1.24K | ﹤0.01% | 4540 |
|
|
2023
Q2 | $3.37K | Buy |
+185
| New | +$3.37K | ﹤0.01% | 4471 |
|
|
2023
Q1 | – | Sell |
-159,446
| Closed | -$3.71M | – | 5567 |
|
|
2022
Q4 | $3.71M | Sell |
159,446
-536,662
| -77% | -$12.5M | ﹤0.01% | 2198 |
|
|
2022
Q3 | $15.4M | Sell |
696,108
-50,672
| -7% | -$1.12M | ﹤0.01% | 1700 |
|
|
2022
Q2 | $14.4M | Sell |
746,780
-287,571
| -28% | -$5.54M | ﹤0.01% | 1792 |
|
|
2022
Q1 | $36.9M | Buy |
1,034,351
+141,824
| +16% | +$5.06M | ﹤0.01% | 1521 |
|
|
2021
Q4 | $77.7M | Sell |
892,527
-274
| -0% | -$23.8K | 0.01% | 1225 |
|
|
2021
Q3 | $101M | Buy |
892,801
+355,375
| +66% | +$40.2M | 0.01% | 1105 |
|
|
2021
Q2 | $111M | Buy |
+537,426
| New | +$111M | 0.01% | 1082 |
|